Sebela Pharmaceuticals is uniquely positioned for significant growth organically and through acquisitions, in-licensing and partnerships. We offer market-leading treatments in gastroenterology, dermatology and women’s health, including:
SUPREP® Bowel Prep Kit (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution, the #1 prescribed branded bowel prep kit1
NAFTIN® GEL 2% (Naftifine HCl), the #1 prescribed brand for interdigital tinea pedis1
Analpram HC® (hydrocortisone acetate 2.5%, pramoxine HCI 1%) cream, the #1 prescribed branded hemorrhoid treatment by gastroenterologists and colorectal surgeons1
Sebela Pharmaceuticals provides resources to healthcare providers including product samples, patient savings cards and patient educational materials. To find a local Sebela Pharmaceuticals sales representative or to request support materials, please call the Sebela Pharmaceuticals Promotional Support line at 1-888-246-1207 or click below.
Sebela Pharmaceuticals is committed to improving patients’ lives by developing, marketing, and selling differentiated brands of prescription pharmaceuticals for patients whose needs are not adequately satisfied. Sebela Pharmaceuticals’ commercial activities are focused on niche therapeutic markets in the United States, including gastroenterology, dermatology and women’s health.
REFERENCE: 1. IQVIA. National Prescription Audit Report. January 2019.